Contact:
Karen Whelan,
Public Relations & Practice Marketing Specialist
Phone: 508-787-1461
kwhelan@optos.com
Optos to Participate in American Academy of Optometry’s Annual Meeting
05.12.2006
MARLBOROUGH, MA, December 5, 2006 – Optos, a leading medical technology company for the design, development, manufacturing, and marketing of retinal imaging devices, will hold key educational activities at the American Academy of Optometry’s (AAO) Annual Meeting, December 7-9, 2006 in Denver, CO.
Optos will host its Optos Academy meeting on Wednesday, December 6th from 4:00 pm to 6:30 pm. A popular workshop series, the Optos Academy is for Optos Partners and other interested doctors which will highlight techniques and best practices created to enable clinicians to achieve the highest level of success with Optos’ technology. The speaker is highly-regarded practice management speaker, David Nelson, OD, MBA who will present “Retina Update: Evaluation, Diagnosis, Management, Coding and Reimbursement Associated with Vitreal/Retinal Conditions.” Attendees will also get a sneak-preview of Optos’ newest software, Version 2.3, which will be available to Partners shortly.
Esteemed speaker, Jerry Sherman, OD, FAAO will present at a free CE Breakfast seminar hosted by Optos on Saturday, December 9th from 7:00 am to 7:50 am, titled, “Advanced Techniques for Fundus Examination and Diagnosis.” Attendees will learn and discuss the advantages of Targeted Ophthalmoscopy in addition to the benefits of Optos’ technology, which provides two procedures in one medical device - optomap® Retinal Exam for wellness exams and the optomap® plus Medical Retinal Exam, used in secondary care where patients have known pathology, which is eligible for reimbursement.
Representatives from Optos will be at its booth, #300, throughout the Academy to meet with Optos Partners as well as educate interested attendees on Optos® technology. Optos encourages attendees to stop by our booth to receive a complimentary optomap® Retinal Exam and learn how this innovative technology – used by more than 2,500 eye care practitioners worldwide – helps with the detection and diagnosis of both eye and non-eye related conditions.
Note to Editors
Optos plc is a leading and rapidly growing medical technology company for the design, development, manufacturing and marketing of devices that image the retina, the light-sensitive area at the back of the eye. Optos' platform technology is the Panoramic200 Scanning Laser Ophthalmoscope device - known as the P200. In a quarter of a second the P200 device produces a high resolution image of up to 200 degrees or approximately 82 percent of the retina in a single capture. The image - branded the optomap® Retinal Exam - provides eye care practitioners with clinically useful information that facilitates the early detection of disorders and diseases evidenced in the retina, such as glaucoma, diabetic retinopathy and age-related macular degeneration.
The Company has recently gained regulatory clearance (CE and FDA 510(k)) to market a second device - P200MA. The P200MA is aimed at the specialist ophthalmic and medical as opposed to the primary care market. It is designed to produce an angiographic retinal image called optomap® fa that supports medical procedures by providing enhanced diagnostic, monitoring and treatment capabilities. Retinal imaging can also indicate evidence of non-eye or systemic diseases such as diabetes, hypertension and certain cancers. Optos’ technology provides an unequalled combination of wide-field retinal imaging, speed and convenience for both practitioner and patient and can help save sight and save lives.
Optos estimates that its P200 device is targeting a recurring US$2 billion market opportunity. As at 30 September 2006 Optos had 232 employees serving more than 2,500 customers in the Company’s existing markets, currently the USA, Canada, UK and Germany. Optos plc is headquartered in Dunfermline, Scotland and was admitted to the Main Market of the London Stock Exchange on 15 February 2006 trading under the symbol OPTS.